Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO)

产生 NIDA 机会的群体合作联盟 (C3PNO)

基本信息

项目摘要

ABSTRACT In response to the Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (Notice Number NOT-DA-20-047 and linked Program Announcement PA-18-591) funding opportunity, the Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO; U24DA044554) proposes a project to assess the impact of COVID-19 on the participating cohorts' population of substance-using people living with HIV (PLWH) and those at high-risk for HIV infection. Our innovative study proposes to collect data from a subset of participants from each of seven participating C3PNO cohorts at two time points – in the height of the COVID-19 pandemic and during its mitigation and control – in order to assess the impact of the COVID-19 epidemic on substance use for PLWH and those at high risk for HIV. We will use our current infrastructure and C3PNO validated harmonization strategies to compile new and existing data across the cohorts in order to: assess changes in social and individual determinants of health during the course of the COVID-19 pandemic, to estimate differences in substance-using behaviors of those who were confirmed/probable cases of COVID-19 (based on self-report or medical record) and those who were not a confirmed/probable case, and to assess how PLWH and people who are at high risk for HIV in C3PNO have different experiences in and responses to the COVID-19 epidemic as compared to other HIV studies and cohorts that have less substance use. The C3PNO Coordinating Center at UCLA and Frontier Science will facilitate the design and implementation of a survey to collect data from a subset of participants from each of seven participating C3PNO cohorts (ALIVE, HYM, JHHCC, MASH, mSTUDY, RADAR, and V-DUS). Participating cohorts will issue the survey to participants and transfer the resulting data to the coordinating center. If funded, this administrative supplement would allow a rapid and coordinated collection of linked COVID-19, HIV, and substance use data related to an ongoing public health emergency affecting the highly vulnerable substance-using populations followed by the cohorts. COVID-19 data harmonization with other HIV cohorts will further aide our collective effort to understand the impact of COVID-19 on HIV impacted communities. Finally, C3PNO's effort to assess changes in social and individual determinants of health during the course of the COVID-19 pandemic as well as estimate differences in substance-using behaviors and the impact on PLWH or at high risk for HIV is both novel and critical in this time of unprecedented social upheaval and instability.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pamina Mae Gorbach其他文献

Pamina Mae Gorbach的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pamina Mae Gorbach', 18)}}的其他基金

Exploring, Predicting, and Intervening on Long-term Viral suppression Electronically (EPI-LoVE)
电子方式探索、预测和干预长期病毒抑制 (EPI-LoVE)
  • 批准号:
    10676683
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
SWG 1 -Translational Research on Substance Use SWG
SWG 1 - 物质使用转化研究 SWG
  • 批准号:
    10609769
  • 财政年份:
    2022
  • 资助金额:
    $ 32.61万
  • 项目类别:
SWG 1 -Translational Research on Substance Use SWG
SWG 1 - 物质使用转化研究 SWG
  • 批准号:
    10458376
  • 财政年份:
    2022
  • 资助金额:
    $ 32.61万
  • 项目类别:
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO)
产生 NIDA 机会的群体合作联盟 (C3PNO)
  • 批准号:
    10552117
  • 财政年份:
    2017
  • 资助金额:
    $ 32.61万
  • 项目类别:
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO)
产生 NIDA 机会的群体合作联盟 (C3PNO)
  • 批准号:
    10352063
  • 财政年份:
    2017
  • 资助金额:
    $ 32.61万
  • 项目类别:
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) Second Bridge Funding Supplement
产生 NIDA 机会的队列合作联盟 (C3PNO) 第二桥资金补充
  • 批准号:
    10609365
  • 财政年份:
    2017
  • 资助金额:
    $ 32.61万
  • 项目类别:
UCLA/Cambodia HIV/AIDS Training Program in Data Management & Analysis
加州大学洛杉矶分校/柬埔寨艾滋病毒/艾滋病数据管理培训计划
  • 批准号:
    8710821
  • 财政年份:
    2014
  • 资助金额:
    $ 32.61万
  • 项目类别:
UCLA/Cambodia HIV/AIDS Training Program in Data Management & Analysis
加州大学洛杉矶分校/柬埔寨艾滋病毒/艾滋病数据管理培训计划
  • 批准号:
    8853361
  • 财政年份:
    2014
  • 资助金额:
    $ 32.61万
  • 项目类别:
UCLA/Cambodia HIV/AIDS Training Program in Data Management & Analysis
加州大学洛杉矶分校/柬埔寨艾滋病毒/艾滋病数据管理培训计划
  • 批准号:
    9050715
  • 财政年份:
    2014
  • 资助金额:
    $ 32.61万
  • 项目类别:
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)
加州大学洛杉矶分校的 MSM 和物质队列将感染注意影响联系起来(男性)
  • 批准号:
    8850993
  • 财政年份:
    2013
  • 资助金额:
    $ 32.61万
  • 项目类别:

相似海外基金

HIV/AIDS prevention and intervention: HIV surveillance methods, Per-exposure prophylaxis eligibility and HIV/STI testing behaviours among a cohort of people living with HIV.
HIV/艾滋病预防和干预:HIV 感染者群体中的 HIV 监测方法、每次暴露预防资格和 HIV/STI 检测行为。
  • 批准号:
    495195
  • 财政年份:
    2023
  • 资助金额:
    $ 32.61万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10013921
  • 财政年份:
    2020
  • 资助金额:
    $ 32.61万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10181081
  • 财政年份:
    2020
  • 资助金额:
    $ 32.61万
  • 项目类别:
UCLA AIDS Prevention and Treatment Clinical Trials Unit
加州大学洛杉矶分校艾滋病预防和治疗临床试验单位
  • 批准号:
    10166309
  • 财政年份:
    2020
  • 资助金额:
    $ 32.61万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10597008
  • 财政年份:
    2020
  • 资助金额:
    $ 32.61万
  • 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
  • 批准号:
    10386931
  • 财政年份:
    2020
  • 资助金额:
    $ 32.61万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    9921510
  • 财政年份:
    2019
  • 资助金额:
    $ 32.61万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    9753631
  • 财政年份:
    2019
  • 资助金额:
    $ 32.61万
  • 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
  • 批准号:
    10265667
  • 财政年份:
    2019
  • 资助金额:
    $ 32.61万
  • 项目类别:
Closing the Gap: Involving Indigenous Elders and youth in HIV/AIDS prevention using participatory filmmaking
缩小差距:利用参与式电影制作让土著老年人和青年参与艾滋病毒/艾滋病预防工作
  • 批准号:
    364681
  • 财政年份:
    2017
  • 资助金额:
    $ 32.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了